After largely running our clinical whole genome sequencing test for #myeloma, JAYseq, in stealth mode for the last 6 months I am extremely proud to see the culmination of years of research effort by my team at TGen and collaborators around the world come to fruition in a clinical test.
Jonathan Keats, PhD 🇨🇦
TGen launches JAYseq, a 72 hour whole genome test for multiple myeloma. TGen’s JAYseq™ test provides oncologists with a comprehensive molecular profile of a patient’s myeloma tumor using a single test.
#MultipleMyeloma #Genomics #PrecisionMedicine #TGen #CityOfHope #MMRF #ALTSeq
